CG Oncology, Inc.·4

May 16, 6:57 PM ET

Patterson Joshua F. 4

4 · CG Oncology, Inc. · Filed May 16, 2024

Insider Transaction Report

Form 4
Period: 2024-05-15
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-15+100,000100,000 total
    Exercise: $28.01Exp: 2034-05-14Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 25% of the underlying shares on June 1, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4